Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2009 - 2026)

Updated

Neurocrine Biosciences (NBIX) recorded Property, Plant & Equipment (Net) of $92.2 million in Q3 2026, down 5.2% from $97.3 million a year earlier but up 1.9% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

At the end of FY2025, Neurocrine Biosciences reported Property, Plant & Equipment (Net) of $89.8 million, up 8.7% from FY2024.

  • Annual Property, Plant & Equipment (Net) has increased for three straight years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • Across earlier years, Property, Plant & Equipment (Net) came in at $82.6 million in FY2024 (+16.7%), $70.8 million in FY2023 (+20.8%), $58.6 million in FY2022 (unchanged) and $58.6 million in FY2021 (+31.4%).
  • Quarterly Property, Plant & Equipment (Net) has ranged from $58.6 million in Q4 2021 to $97.3 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Property, Plant & Equipment (Net) rose in six of the last eight quarters, with growth averaging 9.4%.
  • Peak year-over-year performance for Property, Plant & Equipment (Net) in the last five years was growth of 41.1% in Q1 2022, against a decline of 5.2% in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $90.5 million (Q2 2026), $90.9 million (Q1 2026) and $89.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 32.19 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.94 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 25.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 14.06 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 8.88 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.95 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.05 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 92.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 92.20 Mn
Jun 30, 2026 90.50 Mn
Mar 31, 2026 90.90 Mn
Dec 31, 2025 89.80 Mn
Sep 30, 2025 97.30 Mn
Jun 30, 2025 91.70 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 82.60 Mn
Sep 30, 2024 80.00 Mn
Jun 30, 2024 80.10 Mn
Mar 31, 2024 75.30 Mn
Dec 31, 2023 70.80 Mn
Sep 30, 2023 68.80 Mn
Jun 30, 2023 65.60 Mn
Mar 31, 2023 62.80 Mn
Dec 31, 2022 58.60 Mn
Sep 30, 2022 60.90 Mn
Jun 30, 2022 66.80 Mn
Mar 31, 2022 63.90 Mn
Dec 31, 2021 58.60 Mn
API Access

Neurocrine Biosciences Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=NBIX&period=max&api_key=YOUR_API_KEY